Not admitted · Vague or promotional

After summarizing the JAMA Psychiatry proof-of-concept RCT of tocilizumab (IL-6 inhibition) in difficult-to-treat depression with low-grade inflammation (n=30; no endpoint significant, remission and response favored tocilizumab, baseline hs-CRP tracked improvement). Author suggests his two long-held bets, accelerated dTMS and the inflammation/autoimmune link to depression, will both be borne out.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.